CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...